| Literature DB >> 31270686 |
Barbara Kleinmann1, Tilman Wolter2.
Abstract
Intrathecal drug delivery (IDD) was first described in 1981 by Onofrio, who used a pump for continuous and intrathecal delivery of morphine to treat cancer pain. Over the following four decades, many reports supported this treatment method with implanted pumps for cancer and non-cancer pain. To date, more than 300,000 pumps for pain therapy and spasticity have been implanted worldwide. This article reviews current knowledge regarding intrathecal opioid therapy, focusing particularly on the use of IDD in elderly patients. Current literature is presented, and the arguments in favor of and against this therapy in elderly patients are discussed.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31270686 DOI: 10.1007/s40266-019-00692-7
Source DB: PubMed Journal: Drugs Aging ISSN: 1170-229X Impact factor: 3.923